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Abstract  71 
The nucleus accumbens (NAc) plays a central role in reinforcement and motivation. 72 
Around 95% of the NAc neurons are medium spiny neurons (MSNs), divided into those 73 
expressing dopamine receptor D1 (D1R) or dopamine receptor D2 (D2R). Optogenetic 74 
activation of D2-MSNs increased motivation, whereas inhibition of these neurons produced 75 
the opposite effect. Yet, it is still unclear how activation of D2-MSNs affects other local 76 
neurons/interneurons or input terminals, and how this contributes for motivation 77 
enhancement. To answer this question, in this work we combined optogenetic modulation of 78 
D2-MSNs with in loco pharmacological delivery of specific neurotransmitter antagonists in 79 
rats. 80 
First, we showed that optogenetic activation of D2-MSNs increases motivation in a 81 
progressive ratio task. We demonstrated that this behavioural effect relies on cholinergic-82 
dependent modulation of dopaminergic signalling of ventral tegmental area (VTA) terminals, 83 
which requires D1R and D2R signalling in the NAc. D2-MSN optogenetic activation 84 
decreased ventral pallidum (VP) activity, reducing the inhibitory tone to VTA, leading to 85 
increased dopaminergic activity. Importantly, optogenetic activation of D2-MSN terminals in 86 
the VP was sufficient to recapitulate the motivation enhancement. 87 
In summary, our data suggests that optogenetic stimulation of NAc D2-MSNs indirectly 88 
modulates VTA dopaminergic activity, contributing for increased motivation. Moreover, both 89 
types of dopamine receptors signalling in the NAc are required in order to produce the 90 
positive behavioural effects.  91 
  92 
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Significance statement  93 
The nucleus accumbens (NAc) is a key brain region of the reward system and is crucial 94 
for motivation. We showed that activation of NAc D2-expressing neurons enhances 95 
motivation by modulating VTA dopaminergic activity via ventral pallidum inhibition. The 96 
behavioural effect was dependent on local cholinergic-dependent dopamine release by VTA 97 
terminals that required D1 and D2 dopamine receptors in the NAc.  98 
This study reveals for the first time how D2-MSN stimulation can modulate downstream 99 
regions and local microcircuit to increase motivation. 100 
 101 
 102 
Introduction  103 
Dopaminergic projections from the ventral tegmental area (VTA) to the nucleus 104 
accumbens (NAc) have been classically described as the core of the reward circuit (Wise, 105 
2004). Evidence in animal models and humans showed that the motivational aspects of 106 
reward processing are greatly mediated by these projections (Bailey et al., 2016; Hyman et 107 
al., 2006; Kelley and Berridge, 2002; Wise, 1998). The NAc contains 95% of medium spiny 108 
neurons (MSNs), that are typically divided into those that express dopamine receptor D1 109 
(D1R, D1-MSNs), and those that express dopamine receptor D2 (D2R, D2-MSNs). In 110 
addition to dopaminergic inputs from the VTA, these MSNs receive dense monosynaptic 111 
glutamatergic innervation from the medial prefrontal cortex, hippocampus and amygdala 112 
(Haber, 2003). These MSNs project directly to the VTA through the direct pathway, mediated 113 
exclusively by D1-MSNs, or indirectly via the ventral pallidum (VP) (both D1- and D2-MSNs) 114 
(Kupchik et al., 2015; Lu et al., 1998; Zhou et al., 2003). Additionally, MSNs are known to 115 
synapse within each other (Dobbs et al., 2016; Sesack and Pickel, 1990), maintaining 116 
GABAergic accumbal activity under a balanced control.  117 
The remaining 5% of NAc neurons are local interneurons, that include large tonically 118 
active cholinergic interneurons (CIN), fast spiking (FS) GABAergic interneurons, low 119 
threshold spiking (LTS) interneurons (Soares-Cunha et al., 2016b), as well as less explored 120 
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subtypes, namely tyrosine hydroxylase interneurons (Ibáñez-Sandoval et al., 2015, 2010) 121 
and calretinin interneurons (Tepper and Bolam, 2004). Importantly, both cholinergic and 122 
GABAergic interneurons play a crucial role in NAc activity and response to salient stimuli 123 
and modulate reward-dependent behaviors (Lim et al., 2014; Tepper and Bolam, 2004). 124 
In the past years, compelling data supported a role for D1-MSNs in positive 125 
reinforcement, while D2-MSNs have been mostly associated with aversion. Nonetheless, 126 
recent data emerged in opposition to this dichotomy; whereas the division of direct and 127 
indirect neurons based on the respective expression of D1R and D2R in dorsal striatum 128 
appears to be precise, in the NAc the indirect pathway contains a mixture of D1-MSNs and 129 
D2-MSNs (Kravitz et al., 2012; Lobo et al., 2010). This implies that both NAc D1- and D2-130 
MSNs can inhibit or disinhibit thalamic activity, with clear repercussions in behavior. In 131 
agreement with this view, a previous study showed that activation of either NAc D1- or D2-132 
MSNs is sufficient to increase motivation in a progressive ratio task (PR) (Soares-Cunha et 133 
al., 2016a). In the same direction, in the ventrolateral striatum, both D1- and D2-MSNs are 134 
activated at the trial start cue in the PR test and inhibition of either population immediately 135 
after the cue resulted in decreased motivation (Natsubori et al., 2017).  136 
These seminal findings showed that D2-MSNs play a more pro-motivation/reward role 137 
than initially anticipated, and suggest that the prevailing notion of a functional segregation of 138 
MSNs should be reconsidered. Yet, it is still unclear how activation of D2-MSNs affects other 139 
local neurons/interneurons and downstream regions and how this contributes for motivation 140 
enhancement. Therefore, we combined optogenetic activation of NAc D2-MSNs with in loco 141 
pharmacological delivery of specific antagonists in order to identify the contribution of 142 
different NAc inputs and neuronal populations for motivational drive.  143 
 144 
Materials and methods  145 
Animals 146 
Male Wistar Han rats (2-3 months old at the beginning of the tests) were used. Animals 147 
were maintained under standard laboratory conditions: 12h light/dark cycle (lights on from 148 
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8am to 8pm) and room temperature of 21±1°C, with relative humidity of 50-60%; rats were 149 
individually housed after optical fibre implantation; standard diet (4RF21, Mucedola SRL) 150 
and water were given ad libitum, until the beginning of the behavioural experiments, in which 151 
animals switched to food restriction to maintain 85% of initial body weight. 152 
Behavioural manipulations occurred during the light period of the light/dark cycle. Health 153 
monitoring was performed according to FELASA guidelines (Nicklas et al., 2002). All 154 
procedures were conducted in accordance with European Regulations (European Union 155 
Directive 2010/63/EU). Animal facilities and animals’ experimenters were certified by the 156 
National regulatory entity – DGAV. All protocols were approved by the Ethics Committee of 157 
the ICVS and by DGAV. 158 
 159 
Experimental Design 160 
Group I of animals (nD2-ChR2=10, nD2-eYFP=7), that received intracranial viral injection and 161 
optical fiber placement in the NAc, performed the progressive ratio test (described below) 162 
and were sacrificed 90 minutes after the beginning of the last PR session for c-fos analysis 163 
(Fig. 1-1A). 164 
Group II of animals (nD2-ChR2=8, nD2-eYFP=7), that received intracranial viral injection and 165 
hybrid cannula (optics and fluid) placement in the NAc, performed the progressive ratio test 166 
(described below) and performed two additional PR sessions with antagonist injections. On 167 
day 1, half of the animals received antagonist injection and the other half received vehicle 168 
injection. On day two, animals receiving drug on the first day received vehicle and vice 169 
versa. All animals were treated with vehicle and drug. After behavioral performance, all rats 170 
were sacrificed, and cannula placement and viral expression were confirmed (Fig. 1-1B).  171 
Group III of animals (nD2-ChR2 NAc-VP=8, nD2-eYFP NAc-VP=6), that received intracranial viral 172 
injection in the NAc and optical fiber placement in the VP, performed the progressive ratio 173 
test (described below) (Fig. 1-1C). 174 
Group IV of animals (nD2-ChR2=4) was injected with ChR2 in the NAc, and after 3 weeks 175 
to allow viral expression, in vivo single unit electrophysiological recordings were performed 176 
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(Fig. 1-1D).  177 
 178 
Behavior 179 
Subjects and apparatus 180 
Rats were habituated to 45 mg food pellets (F0021; BioServ), which were used as 181 
reward during the behavioral protocol, one day prior to training initiation. Behavioral sessions 182 
were performed in operant chambers (Med Associates) that contained a central, recessed 183 
magazine to provide access to 45mg food pellets (Bio-Serve), two retractable levers with 184 
cue lights located above them that were located on each side of the magazine. Chamber 185 
illumination was obtained through a 2.8W, 100mA light positioned at the top-center of the 186 
wall opposite to the magazine. The chambers were controlled by a computer equipped with 187 
the Med-PC software (Med Associates).  188 
 189 
Progressive Ratio (PR) schedule of reinforcement  190 
All training sessions started with illumination of the house light that remained until the 191 
end of the session. On the first training session (CRF; continuous reinforcement sessions) 192 
one lever was extended. The lever would remain extended throughout the session, and a 193 
single lever press would deliver a food pellet (maximum of 50 pellets earned within 30min). 194 
In some cases, food pellets were placed behind the lever to promote lever pressing. After 195 
successful completion of the CRF training, rats were trained to lever press on the opposite 196 
lever using the same training procedure. In the 4 following days, the side of the active lever 197 
was alternated between sessions. Then, rats were trained to lever press one time for a 198 
single food pellet in a fixed ratio (FR) schedule consisting in 50 trials in which both levers are 199 
presented, but the active lever is signaled by the illumination of the cue light above it. FR 200 
sessions began with extension of both levers (active and inactive) and illumination of the 201 
house light and the cue light over the active lever. Completion of the correct number of lever 202 
press led to a pellet delivery, retraction of the levers and the cue light turning off for a 20s 203 
ITI. Rats were trained first with one lever active and then with the opposite lever active in 204 
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separate sessions (in the same day). In a similar manner, rats were then trained using an 205 
FR4 reinforcement schedule for 4 days and a FR8 for 1 day. On the test day, rats were 206 
exposed to PR or FR experimental sessions (one session per day) according to the following 207 
schedule: day 1 – FR4; day 2 – PR (Optical stimulation); day 3 – FR4; day 4 – PR (no 208 
optical stimulation). PR sessions were identical to FR4 sessions except that the operant 209 
requirement on each trial (T) was the integer (rounded down) of 1.4(T–1) lever presses, 210 
starting at 1 lever press. PR sessions ended after 15 min elapsed without completion of the 211 
response requirement in a trial.  212 
Before the PR session, rats were connected to an opaque optical fiber, through 213 
previously implanted cannula guide placed in the NAc. At the beginning of each trial of the 214 
PR session with optical stimulation – when the retractable levers are exposed to the animal 215 
together with the cue light – animals received an optical stimulation. After basal assessment 216 
of PR (one session with optical stimulation and one session without), all animals performed 217 
7 additional sessions (with one week interval and 1 FR4 reminder session prior to PR test) 218 
with optical stimulation and local pharmacological administration of receptors antagonist 219 
(Fig. 1-1). 220 
Optical stimulation was performed as follows: 473nm; frequency of 40Hz; 12.5ms pulses 221 
over 1s; 10mW at the tip of the implanted fiber.  222 
 223 
Constructs and virus preparation 224 
eYFP or hChR2(H134R)-eYFP were cloned under the control of the D2R minimal 225 
promoter region as described before (Soares-Cunha et al., 2016a; Zalocusky et al., 2016). 226 
Constructs were packaged in AAV5 serotype by the UNC Gene Therapy Center Vector Core 227 
(UNC). AAV5 vector titters were 3.7-6x1012 viral molecules/ml as determined by dot blot. 228 
 229 
Surgery and cannula implantation  230 
Rats were anesthetized with 75mgkg-1 ketamine (Imalgene, Merial) plus 0.5 mg kg-1 231 
medetomidine (Dorbene, Cymedica). Virus was unilaterally injected into the NAc; 232 
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coordinates from bregma, according to (Paxinos and Watson, 2005): +1.2mm 233 
anteroposterior (AP), +1.2mm mediolateral (ML), and -6.5mm dorsoventral (DV) (D2-ChR2 234 
group and D2-eYFP control group). Rats that performed the PR with only optical stimulation 235 
were implanted with an optic fiber (200μm diameter) attached to a 2.5mm ferrule (Thorlabs), 236 
and rats that performed the PR test with both optical stimulation and local administration of 237 
antagonists were implanted with opto-fluid cannulas (Doric Lenses) using the injection 238 
coordinates (except for the dorsoventral: -6.4mm) that were secured to the skull using 239 
2.4mm screws (Bilaney) and dental cement (C&B kit, Sun Medical).  240 
For NAc terminal stimulation in the VP, virus was injected as above but rats were 241 
implanted with an optic fiber in the VP - coordinates from bregma: -0.1mm AP, +2.4mm ML, 242 
and -7mm DV (D2-ChR2 NAc-VP group and D2-eYFP NAc-VP control group). 243 
Rats were allowed to recover for two weeks before initiation of the behavioural trainings. 244 
 245 
In vivo single-cell electrophysiology 246 
Three weeks post-surgery, D2-ChR2 rats (n=4) were anaesthetized with urethane 247 
(1.44gkg-1, Sigma). The total dose was administered in three separate intraperitoneal 248 
injections, 15min apart. Adequate anesthesia was confirmed by the lack of withdrawal 249 
responses to hindlimb pinching. A recording electrode coupled with a fiber optic patch cable 250 
(Thorlabs) was placed in the NAc (coordinates from bregma: +1.2mm AP, +1.2mm ML, and -251 
6.0 to -7.0mm DV), using a stereotaxic frame (David Kopf Instruments) with non-traumatic 252 
ear bars (Stoeling). Other recording electrodes with fiber optic attached were placed in the 253 
VP (coordinates from bregma: 0 to -0.12mm AP, +2.3 to +2.5mm ML, and -7 to -7.6mm DV) 254 
and in the VTA (coordinates from bregma: -5.3mm AP, +0.9mm ML, and -7.5 to -8.3mm 255 
DV).  256 
Single neuron activity was recorded extracellularly with a tungsten electrode (tip 257 
impedance 5–10 Mat 1kHz) and data sampling was performed using a CED Micro1401 258 
interface and Spike 2 software (Cambridge Electronic Design). The DPSS 473nm laser 259 
system, controlled by a stimulator (Master-8, AMPI) was used for intracranial light delivery. 260 
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Optical stimulation was performed as follows: 473nm; frequency of 40Hz; 12.5ms pulses 261 
over 1s, 10mW.  262 
Firing rate histograms were calculated for the baseline (10s before stimulation), 263 
stimulation period and after stimulation period (10s after the end of stimulation). Spike 264 
latency was determined by measuring the time between half-peak amplitude for the falling 265 
and rising edges of the unfiltered extra-cellular spike. 266 
NAc neurons were classified according to previous descriptions (Jin et al., 2014; Vicente 267 
et al., 2016). In short, fast-spiking interneurons – putative parvalbumin-containing neurons 268 
(pFSs) – were identified has having a waveform half-width of less that 100μs and a baseline 269 
firing rate higher that 10Hz; tonically active putative cholinergic interneurons (pCINs) were 270 
identified as those with a waveform half-width bigger that 300μs. Putative MSNs (pMSNs) 271 
were identified as those with baseline firing rate lower that 5Hz and that do not met the 272 
waveform criteria for pCIN or pFS neurons.  273 
VP GABAergic neurons were identified as those having a baseline firing rate between 274 
0.2 Hz and 18.7 Hz (Richard et al., 2016). Other non-identified neurons (corresponding to 275 
less that 5% of recorded cells) were excluded from the analysis. 276 
Single units in the VTA were separated into those putative dopaminergic (pDAergic) and 277 
putative GABAergic (pGABAergic). This classification was based on firing rate and 278 
waveform duration (Totah et al., 2013; Ungless et al., 2004; Ungless and Grace, 2012). 279 
Cells presenting baseline firing rate lower that 10Hz and a waveform duration higher than 280 
1.5ms were considered pDAergic neurons. Cells presenting baseline firing rate higher than 281 
10Hz and waveform duration lower than 1.5ms were classified as pGABAergic. Other single 282 
units that did not fit in any classification (less than 5% of recorded cells) were excluded from 283 
the analysis. 284 
 285 
Immunofluorescence (IF)  286 
Ninety min after initiation of the PR test, rats were deeply anesthetized with 287 
pentobarbital (Eutasil) and were transcardially perfused with 0.9% saline followed by 4% 288 
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paraformaldehyde. Brains were removed and post-fixed in 4% paraformaldehyde. Coronal 289 
vibratome sections (50μm) were incubated with mouse anti-D2R (1:500, CAT#sc-5303, 290 
RRID: AB_668816, Santa Cruz Biotechnology); rabbit anti-c-fos (1:1000, Merck Millipore 291 
CAT#Ab-5, RRID: AB_2314042), goat or mouse anti-GFP (1:500, Abcam CAT#ab6673, 292 
RRID: AB_305643; or Abcam CAT#ab1218, RRID: AB_298911), mouse anti-D1R (1:100, 293 
Novus CAT#NB110-60017, RRID: AB_905382) and goat anti-ChAT (1:750, Millipore 294 
CAT#AB144P, RRID: AB_2079751). Appropriate secondary fluorescent antibodies were 295 
used (1:500, Invitrogen; CAT# A-21206, RRID:AB_141708; CAT# R37119, 296 
RRID:AB_2556547; CAT# A-21202, RRID:AB_141607; CAT# R37114, RRID:AB_2556542; 297 
CAT# A-11055, RRID:AB_142672). Finally, all sections were stained with 4′,6-diamidino-2-298 
phenylindole (DAPI; 1mgml-1). Anti-D1R and anti-D2R antibodies were previously validated 299 
(Basu et al., 2004; Luedtke et al., 1999; Luessen et al., 2016) (Fig. 5-1). 300 
For each brain region, counting’s were performed in 5 distinct 50μm sections. Images 301 
were collected and analysed by confocal microscopy (Olympus FluoViewTMFV1000). Cell 302 
counts were normalized to the area of the brain region. 303 
 304 
Drugs  305 
All drugs were delivered 10 minutes before animals performed the PR test, through an 306 
opto-fluid system chronically implanted in the NAc. Injections were performed using a 5μL 307 
gastight seringe (Hamilton), attached to the implanted injection cannula of the rats through 308 
22-gauge tubing, at a constant rate of 1μL per minute. 309 
The drugs used in experimental procedures were: R(+)-SCH-23390 hydrochloride (D1R 310 
antagonist, 0.25μg in 0.5μL of saline, Sigma); (S)-(-)-Sulpiride (D2R antagonist, 0.2μg in 311 
1μL, Sigma); Scopolamine Hydrobromide (mAChR antagonist, 25μg in 1μL, Sigma); 312 
Mecamylamine hydrochloride (nAChR antagonist, 22.5μg in 1μL, Sigma); Dihydro-β-313 
erythroidine hydrobromide (DHβE, α4-nAChR antagonist, 0.7μg in 1μL, Tocris); CGP-55845 314 
hydrochloride (GABA(B) receptor antagonist, 44ng in 0.5μL, Sigma); 1(S),9(R)-(-)-Bicuculine 315 
methobromide (GABA(A) receptor antagonist, 75ng in 0.5μL, Sigma). 316 
  13 
 317 
Statistical analysis 318 
Normality tests were performed for all data analysed, as well as outlier analysis using 319 
Tukey’s test. Statistical analysis between two groups was made using two-tailed Student’s t-320 
test (unpaired t-test for comparison between two groups; paired t-test for comparison within 321 
the same group). One-way or two-way analysis of variance (ANOVA) was used when 322 
appropriate. Bonferroni’s post hoc multiple comparisons were used for group differences 323 
determination. Statistical results are displayed in Table 1. 324 
Results are presented as mean ± SEM. All statistical analysis was performed using 325 
GraphPad Prism (v7.0) and results were considered significant for p≤0.05. 326 
 327 
 328 
329 
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Results 330 
Optogenetic stimulation of NAc D2-MSNs increases motivation 331 
In order to specifically modulate the activity of nucleus accumbens (NAc) D2R-332 
expressing neurons, we injected in the NAc of rats a construct containing channelrhodopsin 333 
(ChR2) in fusion with enhanced yellow fluorescent protein (eYFP) under the control of the 334 
D2R minimal promoter (pAAV-D2Rp-hChR2(H134R)-eYFP), or the control eYFP virus 335 
(pAAV-D2Rp-eYFP) (Figs. 1A-B; Fig. 1-2) (Soares-Cunha et al., 2016a; Zalocusky et al., 336 
2016). Nearly 60% of NAc D2R-expressing neurons were successfully transfected with 337 
ChR2 or eYFP (D2R+/eYFP+ cells; Fig. 1C). In addition, only 1.5% of eYFP+ cells were 338 
D1R+; and 2% were ChAT+. Forty % of ChAT+ cells (CINs) were transfected since they 339 
express eYFP (Fig. 1-2).  340 
Using single-cell in vivo electrophysiology, we showed that D2-MSN optical stimulation 341 
(40Hz, 40 light pulses at 12.5ms) significantly increases NAc firing rate during stimulation in 342 
comparison with baseline, and 84% of the cells return to basal activity after stimulation (Fig. 343 
1D-F; F(2,48)=76.7, p<0.000, one-way ANOVA). 68% of recorded cells increased activity, 344 
16% decrease and 24% did not change activity in response to stimulation. Spike latency was 345 
~2ms (Fig. 1G). 346 
After, animals were submitted to PR test (Fig. 1-1) to evaluate their willingness to work 347 
for a food reward, a direct measure of individual motivation. During continuous reinforcement 348 
(CRF) training, both groups increased lever pressing throughout days in a similar manner 349 
(Fig. 1H; F(1,15)=0.43, p=0.522, 2way ANOVA). Likewise, all animals increased lever 350 
pressing in the fixed-ratio (FR) schedule days in the active vs non-active lever (Fig. 1I; 351 
F(3,30)=126.8, p<0.000, 2way ANOVA).  352 
In agreement with previous findings (Soares-Cunha et al., 2016a), D2-MSN optical 353 
stimulation (40 light pulses of 12.5ms at 40Hz) occurring at the same time as the conditioned 354 
stimulus (light above the active lever), induced a significant increase in the breakpoint of D2-355 
ChR2 rats in comparison with D2-eYFP stimulated rats (63.6% increase; Fig. 1J; t(15)=7.7, 356 
p<0.000, unpaired t-test). All D2-ChR2 rats displayed a significant increase in the breakpoint 357 
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in the session with optical stimulation (ON) in comparison with the session without 358 
stimulation (OFF) (Fig. 1K; 2way ANOVA post hoc p<0.000). This increase in motivation was 359 
not due to differences in the number of food pellets earned during the PR session (Fig. 1L; 360 
t(15)=1.5, p=0.1380, unpaired t-test). Stimulation occurring during the inter-trial interval (ITI) 361 
had no effect on motivation (Fig. 1M-N), proving that the positive effect of stimulation in 362 
behavior was restricted to particular stages of the test. 363 
 364 
Increase in motivation is dependent on NAc GABA signaling 365 
MSNs are GABAergic in nature and synapse within each other in the NAc (Dobbs et al., 366 
2016). Besides, local interneurons provide an additional source of GABA that also controls 367 
MSNs activity (Fig. 2A) (Tepper et al., 2004).  368 
To further understand the impact of GABAergic neurotransmission in the control of D2-369 
MSN-mediated enhancement of motivation, we used hybrid cannulas, which allow dual 370 
delivery of drugs and light in the same region (Fig. 1-1; Fig. 2-1). Immediately before 371 
behavioral testing and optogenetic activation of D2-MSNs, we injected in the NAc either a 372 
GABAA receptor antagonist (bicuculline, 75ng) or a GABAB receptor antagonist (CGP 55845 373 
hydrochloride, 44ng), in dosages that have been shown previously to induce a behavioral 374 
effect (Giorgetti et al., 2002; Ikeda et al., 2010; Kandov et al., 2006).  375 
For GABAA receptor antagonist, we found no significant effect of treatment but there 376 
was a group effect, with D2-ChR2 stimulated animals presenting increased breakpoint (Fig. 377 
2B; 2way ANOVA; treatment effect: F(1,13)=0.1, p=0.117; group effect: F(1,13)=118.8, 378 
p<0.000). For GABAB receptor antagonist, there was a significant effect of treatment and 379 
group (Fig. 2C; 2way ANOVA; treatment effect: F(1,13)=30.7, p<0.000; group effect: 380 
F(1,13)=193, p<0.000).  381 
None of the GABA antagonists alters the breakpoint of control D2-eYFP animals (Fig. 382 
2B-C), though there was a trend for increased number of lever presses with GABAB receptor 383 
antagonist treatment (12% increase; p=0.070, 2way ANOVA post hoc). GABAA receptor 384 
antagonist administration prior to D2-MSN stimulation did not impair the breakpoint 385 
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enhancement (Fig. 2B; D2-ChR2 vehicle vs D2-ChR2 GABAA antag, p=0.787, 2way ANOVA 386 
post hoc). However, administration of GABAB receptor antagonist led to an additional 387 
increase in the breakpoint of D2-stimulated animals (15.8% increase; Fig. 2C; p<0.000, 388 
2way ANOVA post hoc). No differences were found between groups in the number of pellets 389 
earned during the session (Fig. 2-2). 390 
These results suggest that GABA signalling arising from MSNs or local interneurons can 391 
modulate motivational drive in a GABAB-dependent manner.  392 
 393 
Increase in motivation is dependent on NAc cholinergic signaling 394 
In addition to GABAergic modulation, MSNs activity is tightly controlled by cholinergic 395 
interneurons (CIN) (Fig. 2A), which are able to control dopamine release from VTA terminals 396 
in the NAc (Cachope et al., 2012), promoting behavioral conditioning (Witten et al., 2010).  397 
Using a similar approach as above, we injected in the NAc a combination of muscarinic 398 
(mAChR) and nicotinic acetylcholine receptor (nAChR) antagonists prior to PR paradigm 399 
(scopolamine, 25μg; mecamylamine, 22.5μg, respectively; dosages previously validated 400 
(Nadal et al., 2002; Perry et al., 2014; Rahman and McBride, 2002; Yee et al., 2011)). 401 
Treatment had a significant effect on behavior (Fig. 2D; F(3,39)=6.3, p=0.001, 2way 402 
ANOVA). Blockade of cholinergic signalling significantly abolished the motivation 403 
enhancement induced by optogenetic D2-MSN activation (Fig. 2D; D2-ChR2 vehicle vs D2-404 
ChR2 mAChR+nAChR antag, p<0.000, 2way ANOVA post hoc).  405 
Further studies using either one of the antagonists revealed that this blockage was 406 
mediated by nAChR (Fig. 2D; D2-ChR2 vehicle vs D2-ChR2 nAChR antag, 2way ANOVA 407 
post hoc, p<0.000). No differences in the number of pellets earned during the session were 408 
found (Fig. 2-2). 409 
In the NAc, MSNs express mAChR (M1 and M4) (Yan et al., 2001) but not nAChR 410 
(Jones et al., 2001; Jones and Wonnacott, 2004). The later receptors are mainly expressed 411 
in VTA dopaminergic terminals (Hill et al., 1993) and some GABAergic interneurons (Koós 412 
and Tepper, 1999) (Fig. 2A). Tonic striatal acetylcholine is able to promote dopamine 413 
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release through beta2-subunit-containing (β2*)-nAChR receptors in VTA terminals (Rice and 414 
Cragg, 2004). Using different KO strains, Champtiaux and colleagues proposed that a 415 
combination of α6β2* and α4β2* nAChRs mediate the endogenous cholinergic modulation of 416 
dopamine release at the terminal level (Champtiaux et al., 2003). Considering this, we 417 
injected DHβE (0.7 μg; dosage validated (Löf et al., 2007)), an antagonist of α4 subunit of 418 
nAChR, in the NAc before performing the PR test. By blocking α4 receptors, we are 419 
abolishing at least 50% of dopamine release in the NAc (Champtiaux et al., 2003).  420 
Treatment using α4 antagonist had a significant effect on behavioral performance (Fig. 421 
2E; F(1,13)=43.0, p<0.000, 2way ANOVA). No effect in the breakpoint of control animals 422 
was found, yet, this treatment abolished the enhancement of breakpoint induced by D2-MSN 423 
stimulation (20.8% decrease; p<0.000, 2way ANOVA post hoc). No effect on the number of 424 
pellets earned during the session was found (Fig. 2-2). 425 
These results suggest that cholinergic activation of VTA terminals is required for the 426 
observed behavioural effect of D2-MSN stimulation.   427 
 428 
Enhancement of motivation by D2-MSN activation requires dopamine signaling 429 
through D1R and D2R 430 
Activating α6β2* and/or α4β2* nAChRs in VTA terminals greatly enhances dopamine 431 
release in the NAc (Cachope et al., 2012; Wonnacott et al., 2000), and our previous results 432 
suggested that cholinergic modulation of VTA terminals was necessary for the observed 433 
motivation enhancement induced by D2-MSN optogenetic activation. Thus, we next tried to 434 
clarify the role of NAc dopamine receptors D1R and D2R in this process. To do so, we 435 
injected in the NAc before performance of PR test with optogenetic stimulation of D2-MSNs, 436 
R(+)-SCH-23390 hydrochloride (0.5 μg; D1R antagonist) or sulpiride (0.2 μg ; D2R 437 
antagonist) in doses that were previously shown to have a behavioural effect (Vezina et al., 438 
1994).  439 
Both D1R and D2R antagonist treatment had a significant effect (Fig. 2F-G; 2way 440 
ANOVA; D1R antag: F(1,13)=65.7, p<0.000; D2R antag: F(1,13)=56.8, p<0.000). 441 
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Interestingly, both antagonists caused a reduction in the breakpoint of control D2-eYFP 442 
animals (D1R antagonist: 25.1% decrease, p=0.047, 2way ANOVA post hoc; D2R 443 
antagonist: 26.2% decrease, p=0.013, 2way ANOVA post hoc).  444 
Additionally, pharmacological inhibition of either D1R or D2R abolished the increase in 445 
motivation induced by D2-MSN optogenetic activation (D2-ChR2 vehicle vs D2-ChR2 D1R 446 
antag: p<0.000, 2way ANOVA post hoc; D2-ChR2 vehicle vs D2-ChR2 D2R antag: p<0.000, 447 
2way ANOVA post hoc). A reduction in the number of pellets consumed in D1R-treated D2-448 
eYFP rats was found (Fig. 2-2, p=0.0164, 2way ANOVA post hoc). No significant differences 449 
in the number of pellets consumed were found in other groups. 450 
These results suggest that the motivation improvement is dependent on both types of 451 
dopamine receptor signalling in the NAc.  452 
 453 
Optogenetic stimulation of NAc D2-MSNs recruits the VP and the VTA 454 
The preceding results suggested a dopamine-dependent effect of D2-MSN optogenetic 455 
activation in motivation (summarized in Fig. 2H). D2-MSNs do not directly project to VTA, 456 
but indirectly modulate VTA dopaminergic activity through the ventral pallidum (VP) 457 
(Floresco et al., 2003; Grace et al., 2007; Hjelmstad et al., 2013; Kupchik et al., 2015; Wu et 458 
al., 1996). So, we next examined the pattern of expression of c-fos, an immediate early gene 459 
used as a marker of neuronal recruitment, after the PR test in the NAc and connected 460 
regions.  461 
Stimulated D2-ChR2 rats showed a significant increase in c-fos staining in NAc D2R-462 
expressing neurons, when compared with stimulated control D2-eYFP rats (Fig. 3A-B; Fig. 463 
3-1; t(13)=12.0, p<0.000, unpaired t-test), and when compared with the non-stimulated side 464 
(t(7)=7.4, p=0.0002, paired t-test). This increase in c-fos expression was also observed in 465 
NAc D1R-expressing neurons when comparing D2-ChR2 with D2-eYFP rats (Figs. 3A, 3C; 466 
t(13)=3.7, p=0.0028, unpaired t-test), and with the contralateral non-stimulated side 467 
(t(7)=5.3, p=0.0011, paired t-test).  468 
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ChAT-expressing neurons also presented increased c-fos expression when comparing 469 
D2-ChR2 with D2-eYFP rats (Figs. 3A, 3D; t(13)=5.7, p<0.000, unpaired t-test), or 470 
comparing with contralateral non-stimulated side (t(7)=4.0, p=0.0053, paired t-test). 471 
In addition, we evaluated the number of c-fos+ cells in accumbal downstream regions: 472 
the VTA, which is innervated solely by NAc D1-MSNs (Bocklisch et al., 2013); the VP, which 473 
is directly innervated by NAc D1- and D2-MSNs (Creed et al., 2016); and the substantia 474 
nigra pars compacta (SNc) as a control region, since it is mainly innervated by dorsal 475 
striatum MSNs (Gerfen, 1984).  476 
A significant increase in VTA c-fos+ cells was observed in D2-ChR2 rats in comparison 477 
to D2-eYFP stimulated rats (Figs. 3E-F; t(13)=5.3, p<0.000, unpaired t-test), or when 478 
comparing with contralateral side (t(7)=4.6, p=0.0024, paired t-test); from these, around 30% 479 
were dopaminergic neurons (t(13)=7.1, p<0.000, unpaired t-test). A similar increase in c-fos 480 
was observed in the VP of D2-ChR2 in comparison with D2-eYFP rats (Fig. 3H-I; t(13)=2.3, 481 
p=0.039, unpaired t-test). However, no significant difference in c-fos was found between 482 
stimulated and contralateral VP in D2-ChR2 rats (t(7)=1.2, p=0.258, paired t-test). D2-MSN 483 
accumbal stimulation did not alter c-fos expression in the SN (Fig. 3G). 484 
 485 
Optogenetic activation of NAc-VP terminals recapitulates motivation enhancement  486 
Next, we analyzed the activity of the VP and VTA during D2-MSN optogenetic 487 
stimulation using in vivo single cell electrophysiology (Fig. 4A).  488 
Concordant with a GABAergic input, NAc D2-MSN stimulation elicited an overall 489 
reduction in the firing rate of the VP (Fig. 4B; F(2,87)=10.6, p<0.000, one-way ANOVA), with 490 
an average spike latency of 5.7ms (Fig. 4-1A), consistent with the expected monosynaptic 491 
input from the NAc to VP. More than 90% of recorded neurons in the VP decreased their 492 
activity during stimulation, which normalized thereafter (Fig. 4C-D).  493 
Conversely, in the VTA, we found a significant increase in global firing rate of putative 494 
VTA dopaminergic neurons (pDAergic) (Fig. 4E; F(2,56)=17.6, p<0.000, one-way ANOVA), 495 
with an average spike latency of 170ms (Fig. 4-1A), indicative of polysynaptic modulation.  496 
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Of these pDAergic neurons, 82.8% increased activity during stimulation (Fig. 4F-G). No 497 
significant differences were observed in the activity of putative GABAergic VTA neurons, 498 
though there was a trend for decreased activity during D2-MSN stimulation (Fig. 4E-G).  499 
The previous data suggested an indirect modulation of VTA activity through the VP, so 500 
we decided to optogenetically stimulate D2-MSN terminals in the VP during the PR test (Fig. 501 
4H-K). Regarding training, both groups learned in a similar manner (CRF: Fig. 4-1B; 502 
F(1,72)=0.0, p=0.856, 2way ANOVA) (FR: Fig. 4-1C; F(3,24)=180.4, p<0.000, 2way 503 
ANOVA).  504 
Optical stimulation (40 light pulses of 12.5ms at 40Hz) of D2-MSN-VP terminals elicited 505 
a significant increase in the breakpoint of ChR2 stimulated rats in comparison with control 506 
stimulated rats (40% increase; Fig. 4I; t(11)=10.7, p<0.000, unpaired t-test). All D2-ChR2 507 
NAc-VP rats displayed a significant increase in breakpoint in the session with optical 508 
stimulation (ON) in comparison with the OFF session (Fig. 4J; t(6)=10.2, p<0.000, paired t-509 
test). No differences in the number of food pellets earned during the PR session was found 510 
(Fig. 4K; t(12)=1.7, p=0.112, unpaired t-test). 511 
 512 
Discussion 513 
Local microcircuits in combination with excitatory and inhibitory inputs from upstream 514 
regions play an important role in striatal function. Here, we show that activation of D2-MSNs 515 
during cue exposure increases willingness to work in the PR test, and that a concerted 516 
action of different neurotransmitter systems in the striatum is required for this behavioral 517 
effect (Fig. 5). 518 
We first evaluated the impact of GABAergic transmission since GABAergic MSNs highly 519 
synapse within each other in the NAc (Dobbs et al., 2016; Sesack and Pickel, 1990), 520 
providing a weak lateral inhibitory network (feedback inhibition) (Tepper et al., 2008). This 521 
MSN-MSN reciprocal regulation mainly occurs in a GABAA receptor mediated manner 522 
(Tunstall et al., 2002). Our results suggest that the D2-MSN-driven enhancement in 523 
motivation is not dependent on GABAergic signalling, since neither GABAA nor GABAB 524 
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antagonists normalized the phenotype. However, we do observe an additional increase in 525 
the breakpoint of both control and D2-MSN stimulated animals upon GABAB antagonist 526 
administration in the NAc. Such finding is likely to rely on enhanced corticostriatal 527 
glutamatergic release upon the blockade of presynaptic GABAB receptors. In fact, MSNs 528 
express GABAB receptors, application of exogenous GABAB agonists does not lead to any 529 
MSN electrophysiological effect (Logie et al., 2013), though it significantly supresses 530 
glutamatergic inputs onto MSNs via a pre-synaptic mechanism (Logie et al., 2013; 531 
Nisenbaum et al., 1993). Apart from classic studies showing that NAc cue-evoked firing is 532 
abolished by VTA inactivation (Yun et al., 2004), there is also evidence that cue-evoked 533 
excitations of NAc core neurons depend on mPFC glutamatergic projections, and contribute 534 
to the behavioral response to reward-predictive cues (Ishikawa et al., 2008).  535 
Yet, it is important to refer that although sparse, GABAergic interneurons (which do not 536 
express D2R) (Tritsch and Sabatini, 2012) display highly branched dendritic and extensive 537 
axonal arborisations (English et al., 2012; Ibáñez-Sandoval et al., 2011; Kawaguchi, 1997)  538 
and are capable of exerting a powerful control over striatal excitability (feed-forward 539 
inhibition) (Tepper et al., 2008, 2004). They also express GABAB receptors (Logie et al., 540 
2013), so the blockage of this specific feed-forward inhibition might also contribute for the 541 
observed increase in motivational drive.  542 
In addition to local GABA control, the striatum also contains CINs, which have both 543 
excitatory and inhibitory effects in striatal MSNs (Pakhotin and Bracci, 2007; Sullivan and 544 
Brake, 2003; Witten et al., 2010). In primates, CINs exhibit multiphasic responses to 545 
motivationally salient stimuli that mirror those of midbrain dopamine neurons, being 546 
important for reward-related learning (Cachope et al., 2012; Joshua et al., 2008; Kitabatake 547 
et al., 2003; Witten et al., 2010). Since 80% of CINs express D2R (Alcantara et al., 2003), 548 
one can argue that our optogenetic stimulation protocol directly activates these interneurons, 549 
enhancing acetylcholine release in the striatum. In line with this, we found an increase in 550 
ChAT+/c-fos+ neurons in stimulated animals.  551 
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In vivo selective activation of CINs is sufficient to elicit dopamine release directly in the 552 
NAc and independently of the soma, by activation of nAChRs in VTA terminals (Cachope et 553 
al., 2012; Threlfell et al., 2012). It has been suggested that these nAChR act as dynamic 554 
detectors of acetylcholine concentrations, enhancing the contrast between tonic and burst 555 
dopaminergic firing (Brunzell et al., 2009). In an elegant study using different KO strains, 556 
Champtiaux and colleagues proposed that a combination of α6β2* and α4β2* nAChRs 557 
mediate endogenous cholinergic modulation of dopamine release at the VTA terminal level 558 
(Champtiaux et al., 2003). Here, we show that α4 antagonist, DH?E, blocks D2-MSN-559 
dependent increase in motivation, suggesting that acetylcholine-mediated dopamine release 560 
from VTA terminals is crucial for the observed behavioural effect. It is important to refer that 561 
besides CINs, the NAc may also receive cholinergic inputs from the laterodorsal tegmentum 562 
(Dautan et al., 2014), though the function of these projections remains completely unknown.  563 
In the NAc, α4 nAChRs subunits are expressed mainly in VTA dopaminergic terminals, 564 
but also in some GABAergic fast spiking interneurons (FSI). So, the observed dampening of 565 
motivation with α4 antagonist could also depend on these interneurons. However, our data 566 
does not support this because GABA receptor antagonists did not abolish the optogenetic-567 
induced behavioural effect.  568 
In addition to local cholinergic control, our data suggests an indirect effect in VTA 569 
dopaminergic activity through the VP. First, c-fos analysis revealed increased recruitment of 570 
both VP and VTA regions. VP data is somehow surprising considering the GABAergic nature 571 
of accumbal-VP monosynaptic projections (Kupchik et al., 2015; Root et al., 2010). Though 572 
most studies associate c-fos expression with increased neuronal activity, at least one study 573 
has shown that activating striatal MSNs increases c-fos in the VP (Page and Everitt, 1993). 574 
Yet, rather than directly associate D2-MSN activation with this increase in c-fos in the VP, 575 
we just aim to illustrate that the VP is being differently recruited in stimulated animals. In 576 
fact, animals were sacrificed 90 min after the beginning of the PR test, so c-fos reactivity is a 577 
sum of all neuronal events that occur during the test, and do not reflect only the optogenetic 578 
activation period.  579 
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D2-MSN stimulation decreased VP firing rate, and indirectly increased VTA 580 
dopaminergic activity, with less effects in GABAergic VTA neurons, consistent with the 581 
preferential innervation of VTA dopaminergic neurons by VP inputs (Mahler et al., 2014). So, 582 
our hypothesis is that D2-MSNs reduce the tonic VP-VTA inhibitory input, contributing for 583 
enhanced dopaminergic activity, which is known to boost motivational drive (Cagniard et al., 584 
2006; Peciña et al., 2003). In fact, it was shown that inhibition of NAc afferents to the VP or 585 
direct infusion of GABAergic agonists into the VP, selectively increased the population 586 
activity of dopamine neurons, rising NAc dopamine efflux (Floresco et al., 2003). In line with 587 
this, we showed that optogenetic activation of D2-MSNs terminals in the VP was sufficient to 588 
increase motivation. These findings are in agreement with the emerging notion that the VP is 589 
crucial for reward and motivation towards natural rewards and drugs of abuse. In fact, 590 
different subregions of the VP mediate different aspects of rewarded behavior, from 591 
motivation/incentive salience to reward prediction and consumption (Root et al., 2015; Smith 592 
et al., 2009). Yet, it is important to refer that VP is not only a relay area for indirect NAc 593 
inputs, since VP neuron responses can occur at a shorter latency than cue-elicited 594 
responses in NAc neurons (Richard et al., 2016), and that VP firing rate reflects the strength 595 
of incentive motivation (Ahrens et al., 2016).  596 
The increased dopaminergic signals arising from the VTA act mainly (not exclusively 597 
since some interneurons also express dopamine receptors) on MSNs either by activating 598 
D1R or D2R. Local administration of either D1R or D2R antagonists decreases motivation in 599 
control animals, and also abolished D2-MSN-induced positive effects in motivation, 600 
indicating a synergistic effect of both MSNs populations. In this perspective, it is important to 601 
refer that blockade of D2R would be expected to enhance activity of D2-MSNs since D2Rs 602 
are coupled to inhibitory G-proteins (Beaulieu and Gainetdinov, 2011). Yet, one has to bear 603 
in mind that D2R antagonists can also act in D2 auto-receptors in VTA terminals, 604 
disinhibiting presynaptic control of dopamine release (Anzalone et al., 2012).  605 
Interestingly, D2-MSN optogenetic activation during cue exposure also indirectly 606 
recruited D1-MSNs, as assessed by an increase in the number of D1+/c-fos+ cells in the NAc 607 
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upon stimulation. Considering the proposed role for D1R-expressing neurons in 608 
reinforcement (Kravitz et al., 2012; Lobo et al., 2010), this activation probably also 609 
contributes for the behavioral output.  610 
 611 
In summary, we show that NAc D2-MSN optogenetic activation enhances motivation 612 
through enhanced VTA-driven dopaminergic signalling. The behavioural effect was 613 
dependent on both D1R and D2R signalling in the NAc, suggesting that a coordinated action 614 
between these two striatal populations is needed to increase motivational levels. 615 
 616 
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Legends to Figures 845 
 846 
 847 
Fig. 1. Optical stimulation of NAc D2-MSNs increases motivation. A, AAV5-D2-848 
ChR2(H134R)-eYFP (D2-ChR2 group) or AAV5-D2-eYFP (D2-eYFP group) was unilaterally 849 
injected in the NAc of Wistar han rats. An hybrid cannula was placed in the NAc to allow 850 
simultaneous delivery of fluids and optical stimulation. B, Expression of eYFP was confirmed 851 
by YFP immunostaining; scale bar=500μm; numbers represent distance to bregma in mm. 852 
C, Representative immunostaining for D2R and eYFP in the NAc of an animal injected with 853 
AAV5-D2-ChR2(H134R)-eYFP; scale bar=100μm, inset scale bar=50 μm. More than 50% of 854 
D2-MSNs were transfected (n=6 animals/group). D, Upon D2-MSN optical stimulation 855 
(12.5ms light pulses at 40Hz, during 1s), 60% of cells increased activity, 16% decreased and 856 
24% did not respond in comparison with baseline (n=25 cells from 4 rats). E, Time histogram 857 
of NAc electrophysiological single units in response to optical stimulus (average of 25 cells; 858 
blue stripe corresponds to laser stimulation); E’, example of a ChR2 neuron that responds to 859 
each pulse of stimulation; right: example of a representative MSN waveform. F, Increase in 860 
NAc average firing rate during optogenetic stimulation of D2-MSNs. G, Spike latency in 861 
response to D2-MSN optical stimulation. H, Continuous reinforcement (CRF) training 862 
sessions of the PR test. I, Fixed ratio (FR) training sessions of the PR test. J, Optogenetic 863 
activation of D2-MSNs during cue exposure strongly enhanced breakpoint. K, All animals 864 
increase breakpoint in the session with D2-MSN stimulation (ON) versus OFF session. L, 865 
Number of pellets consumed in the PR session with stimulation was similar between groups. 866 
M, Optogenetic activation of D2-MSNs during inter-trial interval (ITI) does not alter 867 
breakpoint. N, Number of pellets earned in the PR session with stimulation on ITI was similar 868 
between groups. nD2-eYFP=7; nD2-ChR2=10. Error bars denote SEM. ***p<0.001. See extended 869 
data – Fig. 1-1, 1-2. 870 
 871 
 872 
Fig. 2. Effects of different antagonists in motivation. A, Simplified schematic 873 
representation of NAc microcircuit. Left: The NAc receives cortical (PFC) glutamatergic 874 
inputs and VTA dopaminergic inputs. NAc D1- and D2-MSNs send GABAergic projections to 875 
ventral pallidum (VP), which in turn projects back to the NAc (not represented) and to VTA 876 
(amongst other regions). Besides MSNs, the NAc contains cholinergic interneurons (CIN) 877 
and GABAergic interneurons of different natures, including fast spiking interneurons (FSI), 878 
which tightly regulate striatal activity. Right: expression of different neurotransmitter 879 
receptors in striatal neurons and terminals. Of relevance to mention that CINs also express 880 
dopamine receptor D2R, and can stimulate dopamine release from VTA terminals mainly in 881 
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a ?4?2*nAchR or ?6?2*nAchR-dependent manner. Activation of D2R autoreceptors located 882 
in VTA terminals also controls dopamine release. iGluR: ionotropic glutamate receptors; 883 
mGluR: metabotropic glutamate receptors; nAchR: nicotinic (ionotropic) cholinergic 884 
receptors; M1/M4: muscarinic (metabotropic) cholinergic receptors. B-G, Effects of different 885 
receptor antagonists in behavior. Rats were injected in the NAc with a specific antagonist 886 
immediately before the PR test with D2-MSN optogenetic activation. B, GABAA receptor 887 
antagonist did not alter breakpoint of control D2-eYFP animals, nor of D2-ChR2-stimulated 888 
animals. C, GABAB receptor antagonist did not alter breakpoint of control animals, but it 889 
further increased the breakpoint of D2-ChR2 stimulated animals. D, Injection of mAChR + 890 
nAChR antagonist combination abolished the increased breakpoint of D2-ChR2 stimulated 891 
animals. This effect is mediated mainly by nAChR since mecamylamine per se normalized 892 
breakpoint. E, Local administration of α4-nAChR antagonist blocked the effect of D2-MSN 893 
optogenetic activation. F, D1R antagonist decreases the breakpoint of control D2-eYFP 894 
animals. In addition, the breakpoint enhancement induced by optogenetic activation of D2-895 
MSNs was completely abolished by this treatment. G, D2R antagonist originated a similar 896 
effect as D1R antagonist. H, Summary of the effects of different antagonists in the 897 
breakpoint of stimulated D2-eYFP and D2-ChR2 animals. (nD2-eYFP =7; nD2-ChR2=8).  Error 898 
bars denote SEM. * p<0.05, **p<0.01, *** p<0.001, # p<0.001 and refers to the comparison 899 
D2-eYFP treated vs D2-ChR2 treated. See extended data – Fig. 2-1, 2-2. 900 
 901 
 902 
Fig. 3. Effect of optogenetic activation of D2-MSNs in the NAc and downstream 903 
targets. A, Representative immunostaining c-fos and D2R, D1R or ChAT in the NAc; scale 904 
bar=80μm; (nD2-ChR2=8; nD2-eYFP=7). B, Counting of D2R+ and c-fos+ cells in the NAc. D2-MSN 905 
stimulation recruits more D2+ neurons in comparison to non-stimulated side (contralateral). 906 
Stimulated D2-ChR2 animals present increased number of D2+/c-fos+ neurons in 907 
comparison to stimulated D2-eYFP animals (control group). C, Counting of D1R+ and c-fos+ 908 
cells in the NAc, showing an increase in D1+/c-fos+ in stimulated vs contralateral side (or vs 909 
D2-eYFP-stimulated animals). D, Counting of ChAT+ and c-fos+ cells in the NAc, showing an 910 
increase in ChAT+/c-fos+ in stimulated vs contralateral side (or vs D2-eYFP-stimulated 911 
animals. E, Representative immunostaining for TH and c-fos in the VTA (scale bar=100μm) 912 
and F, respective quantification of positive cells. D2-MSN stimulation increases the number 913 
of TH+ neurons in the VTA. G, SN c-fos+ cells counting showing no effect of stimulation. H 914 
Representative immunostaining for c-fos in the VP (scale bar=500μm, inset=100μm) and I, 915 
Stimulated D2-ChR2 animals present increased c-fos staining in the VP comparison to 916 
control D2-eYFP animals; interestingly, no significant differences were found between 917 
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stimulated vs non-stimulated side. Error bars denote SEM. *p<0.05, **p<0.01, ***p<0.001. 918 
SNc: substantia nigra pars compacta. See extended data – Fig. 3-1. 919 
 920 
 921 
Fig. 4. Activation of D2-MSN terminals in the ventral pallidum (VP) increases 922 
motivation.  A, Schematic representation of the in vivo single-cell electrophysiological 923 
recordings with optogenetic manipulation of NAc D2-MSN cell bodies.  B, NAc D2-MSN 924 
optical stimulation (40 Hz, 12.5 ms pulses for 1s) decrease net firing rate of VP neurons. C, 925 
93.3% of VP cells decrease firing rate and 6.7% did not respond to stimulation (n=30 cells/4 926 
rats). D, Time histogram showing the number of events in the VP before, during and after a 927 
40Hz stimulus of NAc D2-MSNs. E, D2-MSN optical stimulation increase the net firing rate of 928 
putative dopaminergic (pDAergic) neurons of the VTA, with no significant changes in the net 929 
firing rate of putative GABAergic neurons (pGABAergic) (npDAergic=29 cells/4 rats; 930 
nGABAergic=5cells/4rats). F, 82.8% of pDAergic cells increased firing rate in response to 931 
stimulation; most of cells returned to baseline activity after the stimulus. pGABAergic 932 
neurons presented a majority of inhibitory responses to D2-MSN stimulation. G, Time 933 
histogram showing the number of events in the VTA before, during and after a 40Hz 934 
stimulus of NAc D2-MSNs. H, Strategy used for optogenetic stimulation of D2-MSN 935 
terminals in the VP (D2-ChR2 NAc-VP group). I, Optogenetic activation of D2-MSN-VP 936 
terminals during cue exposure strongly enhanced breakpoint. J, All animals increase 937 
breakpoint in the session with stimulation (ON) vs non-stimulation session (OFF). K, Number 938 
of pellets consumed in the PR session was similar between groups. (nD2-eYFP NAc-VP =6; nD2-939 
ChR2 NAc-VP=8).  Error bars denote SEM. *** p<0.001. See extended data – Fig. 4-1. 940 
 941 
 942 
Fig. 5. Proposed model for D2-MSN optogenetic activation effects in NAc microcircuit. 943 
NAc D2-MSNs send GABAergic projections to VP neurons, which in turn provide a tonic 944 
inhibitory input to the VTA. (1) Optogenetic activation of D2-MSNs reduces VP net activity 945 
(2), reducing VP-to-VTA inhibitory tone (3). This triggers an increase in VTA dopaminergic 946 
activity (4). These VTA dopaminergic signals require D1R and D2R signalling in the NAc (5’, 947 
5). Interestingly, cholinergic-dependent control of VTA dopaminergic terminals in the NAc 948 
(via ?4-nAChR) is essential for this process (6). (7) Optical stimulation can also be activating 949 
D2-expressing cholinergic interneurons (CIN) that strongly influence dopamine release and 950 
shape behavior.   951 
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Legends to Extended Data 952 
 953 
Fig. 1-1. Experimental design. A, Animals from Group I were subjected to stereotaxic 954 
surgeries for injection of D2-ChR2 or D2-eYFP and optic fiber placement in the nucleus 955 
accumbens (NAc), and let to recover from surgery for 2 weeks; after recovering, animals 956 
performed the progressive ratio (PR) task. On the PR session day, animals were sacrificed 957 
90 minutes after the beginning of the session for c-fos analysis and immunofluorescence 958 
analysis. B, Animals from Group II were subjected to the same protocol as Group I; one 959 
week after performing behavior in naïve conditions, animals were injected in the NAc on one 960 
day with the drug and on the other day with vehicle (counterbalanced within groups for 961 
treatment between the two test days) before PR performance. This test was repeated for all 962 
drugs with one week of interval between treatments. C, Animals from Group III were 963 
subjected to stereotaxic surgeries for injection of D2-ChR2 or D2-eYFP in the NAc and optic 964 
fiber placement in the ventral pallidum (VP), and performed the PR task as above. D, 965 
Animals from Group IV were subjected to the same NAc surgery and were used for in vivo 966 
single cell electrophysiological recordings in the NAc, VP and VTA. 967 
 968 
  969 
Fig. 1-2. Confirmation of optic fiber location and expression specificity of Group I. A, Optic 970 
fiber placement for D2-eYFP (grey) and D2-ChR2 (blue) rats (nD2-eYFP=7; nD2-ChR2=10). B, 971 
Number of D2R+ and eYFP+ cells per area as evaluated by immunofluorescence. Almost all 972 
of eYFP+ cells are also D2R+, confirming the specificity of the construct. C, Number of D1R+ 973 
and eYFP+ cells per area. D, Number of ChAT+ and eYFP+ cells. Only a few D1R+ and 974 
ChAT+ cells express the construct (nD2-eYFP=6; nD2-ChR2=6). Error bars denote SEM. 975 
 976 
  977 
Fig. 2-1. Representative image of viral infection extent and cannula entry site (numbers 978 
represent distance to bregma; scale bar=1mm); optic fiber placement for D2-eYFP (grey) 979 
and D2-ChR2 (blue) rats of Group II (nD2-eYFP=7; nD2-ChR2=8). 980 
 981 
 982 
Fig. 2-2. Number of pellets consumed during the PR session with optical stimulation with 983 
previous administration of different antagonists. A, GABAA receptor antagonist (bicuculline, 984 
75ng). B, GABAB receptor antagonist (GCP-55845, 44ng). C, mAChR antagonist 985 
(scopolamine, 25μg) + nAChR antagonist (mecamylamine, 22.5μg). D, α4-nAChR 986 
antagonist (DHβE, 0.7μg). E, D1R antagonist (SCH-23390, 0.25μg). F, D2R antagonist 987 
(sulpiride, 0.2μg). Error bars denote SEM. *p<0.05. 988 
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Fig. 3-1. Immunofluorescence against GFP and dopamine receptor D1 or dopamine 989 
receptor D2 in D2-EGFP reporter strain. A, Representative image of a section of a D2-990 
GFP animal labelled with anti-GFP and anti-dopamine receptor D2 (scale bar=50μm). B, 991 
Representative image of a section of a D2-GFP animal labelled with anti-GFP and anti-992 
dopamine receptor D1 (scale bar=50μm). C, Respective quantification of 993 
immunofluorescence. 54.4% of total cells were GFP+, in agreement with half of the NAc cells 994 
being D2-MSNs. Of those GFP+ cells, 83% were D2R+ and 17% D2R-; whereas most (73%) 995 
of these cells were D1R-. Error bars denote SEM.  996 
 997 
 998 
Fig. 4.1 Additional data from optogenetic activation experiments. A, Spike latency in 999 
the VP and VTA neurons in response to NAc D2-MSN optogenetic stimulation. VP neurons 1000 
present reduced spike latency to fire, consistent with a monosynaptic input from D2-MSNs,  1001 
whereas VTA neurons present spike latencies indicative of polysynaptic modulation. B-C, 1002 
CRF and FR learning curves of D2-eYFP and D2-ChR2 NAc-VP animals.  1003 
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Table 1. Statistical table 
 
Figure Data Structure Sample size Type of Test Statistics 
1F 
Normal 
distribution 
23 cells from 4 rats one-way ANOVA  F(2,48)=74.7, p<0.000 
1H 
Normal 
distribution 
nD2-eYFP=7; nD2-ChR2=10 2way ANOVA F(1,13)=0.43, p=0.322 
1I 
Normal 
distribution 
nD2-eYFP=7; nD2-ChR2=10 2way ANOVA F(3,30)=124.8, p<0.000 
1J 
Normal 
distribution 
nD2-eYFP=7; nD2-ChR2=10 
Unpaired t-test, 
tailed 
t(13)=7.7, p<0.000 
1K 
Normal 
distribution 
nD2-eYFP=7; nD2-ChR2=10 2way ANOVA  
Laser effect: F(1,13)=47.3, p<0.000 
Group effect: F(1,13)=7.9, p<0.000
Bonferroni post test: 
D2-ChR2 ON vs D2-ChR2 OFF: 
p<0.001 
1L 
Normal 
distribution 
nD2-eYFP=7; nD2-ChR2=10 
Unpaired t-test, 
two tailed 
t(13)=1.3, p=0.1380 
1M 
Normal 
distribution 
nD2-eYFP=7; nD2-ChR2=10 
Unpaired t-test, 
two tailed 
t(13)=0.7, p=0.4719 
1N 
Normal 
distribution 
nD2-eYFP=7; nD2-ChR2=10 
Unpaired t-test, 
two tailed 
t(13)=1.0, p=0.3124 
2B 
Normal 
distribution 
nD2-eYFP veh=7; nD2-eYFP GABAA antag=7; 
nD2-ChR2 veh=8; nD2-ChR2 GABAA antag=8 
2way ANOVA 
Treatment effect:  
F(1,13)=0.1, p=0.117 
Group effect:  
F(1,13)=118.8, p<0.000 
Bonferroni post test: 
D2-ChR2 vehicle vs D2-ChR2 
GABA(A) antag: p=0.787 
2C 
Normal 
distribution 
nD2-eYFP veh=7; nD2-eYFP GABAB antag=7; 
nD2-ChR2 veh=8; nD2-ChR2 GABAB antag=8 
2way ANOVA 
Treatment effect:  
F(1,13)=30.7, p<0.000 
Group effect:  
F(1,13)=193, p<0.000 
Bonferroni post test: 
D2-eYFP vehicle vs D2-eYFP GABA(B) 
antag: p=0.07 
D2-ChR2 vehicle vs D2-ChR2 
GABA(B) antag: p<0.000 
2D 
Normal 
distribution 
nD2-eYFP veh=7; nD2-eYFP mAChR+nAChR 
antag=7; nD2-eYFP mAChR antag=7; nD2-eYFP 
nAChR antag=7; nD2-ChR2 veh=8; nD2-ChR2 
mAChR+nAChR antag=8; nD2-ChR2 mAChR 
antag=8; nD2-ChR2 nAChR antag=8 
2way ANOVA 
Treatment effect:  
F(3,39)=4.3, p=0.001 
Bonferroni post test: 
D2-ChR2 vehicle vs D2-ChR2 
mAChR+nAChR antag: p<0.000 
D2-ChR2 vehicle vs D2-ChR2 nAChR 
antag: p<0.000 
2E 
Normal 
distribution 
nD2-eYFP veh=7; nD2-eYFP -nAChR 
antag=7; nD2-ChR2 veh=8; nD2-ChR2 -
nAChR antag=8 
2way ANOVA  
Treatment effect:  
F(1,13)=43.0, p<0.000 
Bonferroni post test: 
D2-ChR2 vehicle vs D2-ChR2 α4 
antag: p<0.000 
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2F 
Normal 
distribution 
nD2-eYFP veh=7; nD2-eYFP D1R antag=7; nD2-
ChR2 veh=8; nD2-ChR2 D1R antag=8 
2way ANOVA 
Treatment effect:  
D1R antag: F(1,13)=43.7, p<0.000 
Bonferroni post test: 
D2-eYFP vehicle vs D2-eYFP D1R 
antag: p=0.047 
D2-ChR2 vehicle vs D2-ChR2 D1R 
antag: p<0.000 
2G 
Normal 
distribution 
nD2-eYFP veh=7; nD2-eYFP D2R antag=7; nD2-
ChR2 veh=8; nD2-ChR2 D2R antag=8 
2way ANOVA 
Treatment effect:  
D2R antag: F(1,13)=34.8, p<0.000 
Bonferroni post test: 
D2-eYFP vehicle vs D2-eYFP D2R 
antag: p=0.013 
D2-ChR2 vehicle vs D2-ChR2 D2R 
antag: p<0.000 
3B 
Normal 
distribution 
nD2-ChR2=8; nD2-eYFP=7 
Unpaired t-test, 
two tailed 
D2-ChR2 vs D2-eYFP rats:  t(13)=12.0, 
p<0.000 
3B 
Normal 
distribution 
nD2-ChR2=8 
Paired t-test, two 
tailed 
Stimulated vs contralateral side: 
t(7)=7.4, p=0.0002 
3C 
Normal 
distribution 
nD2-ChR2=8; nD2-eYFP=7 
Unpaired t-test, 
two tailed 
D2-ChR2 vs D2-eYFP rats:   t(13)=3.7, 
p=0.0028 
3C 
Normal 
distribution 
nD2-ChR2=8 
Paired t-test, two 
tailed 
Stimulated vs contralateral side: 
t(7)=3.3, p=0.0011 
3D 
Normal 
distribution 
nD2-ChR2=8; nD2-eYFP=7 
Unpaired t-test, 
two tailed 
D2-ChR2 vs D2-eYFP rats:  t(13)=3.7, 
p<0.000 
3D 
Normal 
distribution 
nD2-ChR2=8 
Paired t-test, two 
tailed 
Stimulated vs contralateral side: 
t(7)=4.0, p=0.0033 
3F 
Normal 
distribution 
nD2-ChR2=8; nD2-eYFP=7 
Unpaired t-test, 
two tailed 
D2-ChR2 vs D2-eYFP rats:  t(13)=3.3, 
p<0.000 
3F 
Normal 
distribution 
nD2-ChR2=8 
Paired t-test, two 
tailed 
Stimulated vs contralateral side: 
t(7)=4.4, p=0.0024 
3G 
Normal 
distribution 
nD2-ChR2=8; nD2-eYFP=7 
Unpaired t-test, 
two tailed 
D2-ChR2 vs D2-eYFP rats: 
t(13)=0.3, p=0.418 
3G 
Normal 
distribution 
nD2-ChR2=8 
Paired t-test, two 
tailed 
Stimulated vs contralateral side: 
t(7)=0.1, p=0.9099 
3I 
Normal 
distribution 
nD2-ChR2=8; nD2-eYFP=7 
Unpaired t-test, 
two tailed 
D2-ChR2 vs D2-eYFP rats:  t(13)=2.3, 
p=0.039 
3I 
Normal 
distribution 
nD2-ChR2=8 
Paired t-test, two 
tailed 
Stimulated vs contralateral side: 
t(7)=1.2, p=0.238 
4B 
Normal 
distribution 
30 cells from 4 rats one-way ANOVA F(2,87)=10.4, p<0.000 
4E 
Normal 
distribution 
29 pDAergic cells from 4 rats 
3 pGABAergic cells from 4 rats 
one-way ANOVA 
pDAergic: 
F(2,34)=17.4, p<0.000 
pGABAergic: 
F(2,8)=2.7, p=0.1343 
 
4I Normal nD2-ChR2 NAc-VP=8, nD2-eYFP NAc-VP=4 Unpaired t-test, t(11)=10.7, p<0.000 
  3 
distribution two tailed 
4J 
Normal 
distribution 
nD2-ChR2 NAc-VP=8,  
Paired t-test, two 
tailed 
t(4)=10.2, p<0.000 
4K 
Normal 
distribution 
nD2-ChR2 NAc-VP=8, nD2-eYFP NAc-VP=4 
Unpaired t-test, 
two tailed 
t(12)=1.7, p=0.112 
2-2A 
Normal 
distribution 
nD2-eYFP veh=7; nD2-eYFP GABAA antag=7; 
nD2-ChR2 veh=8; nD2-ChR2 GABAA antag=8 
2way ANOVA 
Bonferroni post test: 
D2-eYFP vehicle vs D2-eYFP antag: 
p=0.4831 
D2-ChR2 vehicle vs D2-ChR2 antag: 
p=0.7434 
2-2B 
Normal 
distribution 
nD2-eYFP veh=7; nD2-eYFP GABAB antag=7; 
nD2-ChR2 veh=8; nD2-ChR2 GABAB antag=8 
2way ANOVA 
Bonferroni post test: 
D2-eYFP vehicle vs D2-eYFP antag: 
p=0.7334  
D2-ChR2 vehicle vs D2-ChR2 antag: 
p=0.9332 
2-2C 
Normal 
distribution 
nD2-eYFP veh=7; nD2-eYFP mAChR+nAChR 
antag=7; nD2-eYFP mAChR antag=7; nD2-eYFP 
nAChR antag=7; nD2-ChR2 veh=8; nD2-ChR2 
mAChR+nAChR antag=8; nD2-ChR2 mAChR 
antag=8; nD2-ChR2 nAChR antag=8 
2way ANOVA 
Bonferroni post test: 
D2-eYFP vehicle vs D2-eYFP 
mAChR+nAChR  antag: p=0.9994  
D2-ChR2 vehicle vs D2-ChR2  
mAChR+nAChR  antag: p=0.9883 
 
D2-eYFP vehicle vs D2-eYFP mAChR  
antag: p=0.9994  
D2-ChR2 vehicle vs D2-ChR2  mAChR
antag: p=0.9883 
 
D2-eYFP vehicle vs D2-eYFP nAChR  
antag: p=0.4483 
D2-ChR2 vehicle vs D2-ChR2  nAChR  
antag: p=0.9187 
 
2-2D 
Normal 
distribution 
nD2-eYFP veh=7; nD2-eYFP -nAChR 
antag=7; nD2-ChR2 veh=8; nD2-ChR2 -
nAChR antag=8 
2way ANOVA  
Bonferroni post test: 
D2-eYFP vehicle vs D2-eYFP antag: 
p=0.4489 
D2-ChR2 vehicle vs D2-ChR2 antag: 
p=0.7023 
2-2E 
Normal 
distribution 
nD2-eYFP veh=7; nD2-eYFP D1R antag=7; nD2-
ChR2 veh=8; nD2-ChR2 D1R antag=8 
2way ANOVA 
Bonferroni post test: 
D2-eYFP vehicle vs D2-eYFP antag: 
p=0.0144 
D2-ChR2 vehicle vs D2-ChR2 antag: 
p=0.0842 
2-2F 
Normal 
distribution 
nD2-eYFP veh=7; nD2-eYFP D2R antag=7; nD2-
ChR2 veh=8; nD2-ChR2 D2R antag=8 
2way ANOVA 
Bonferroni post test: 
D2-eYFP vehicle vs D2-eYFP antag: 
p=0.9999 
D2-ChR2 vehicle vs D2-ChR2 antag: 
p=0.2308 
4-1B 
Normal 
distribution 
nD2-ChR2 NAc-VP=8, nD2-eYFP NAc-VP=6 2way ANOVA 
Group effect: 
F(1,72)=0.0, p=0.856 
4-1C 
Normal 
distribution 
nD2-ChR2 NAc-VP=8, nD2-eYFP NAc-VP=6 2way ANOVA 
Day of training effect: 
F(3,24)=180.4, p<0.000 
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